Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Taiwan J Obstet Gynecol ; 63(1): 90-94, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-38216278

RESUMO

OBJECTIVE: Ovarian clear cell carcinoma has a poor prognosis in comparison with other pathological types of epithelial ovarian carcinoma. It also has relative resistance to first-line platinum-based chemotherapy with a great risk of recurrence. CASE REPORT: We report a case of recurrent ovarian clear cell carcinoma status after left salpingo-oophorectomy (fertility-sparing debulking operation) and six courses of adjuvant chemotherapy (paclitaxel (175 mg/m2)/carboplatin (AUC 6)). However, two years after diagnosis, elevated CA-125 accompanied by an intrapelvic mass was noted. Uterine intramural recurrence was found during the second laparotomy. She was treated with right salpingo-oophorectomy and abdominal hysterectomy combined with systemic chemotherapy administration (paclitaxel (175 mg/m2)/carboplatin (AUC 6)) and maintenance therapy (bevacizumab (7.5 mg/kg)). There was no other recurrence until one and a half years postoperatively, and the patient was tumor free with regular follow-up. CONCLUSION: In young patients with stage I ovarian clear cell carcinoma, fertility-sparing surgery was considered. Most patients will suffer from tumor recurrence, and also intrauterine recurrence rarely happen.


Assuntos
Adenocarcinoma de Células Claras , Neoplasias Ovarianas , Feminino , Humanos , Neoplasias Ovarianas/cirurgia , Neoplasias Ovarianas/tratamento farmacológico , Carboplatina , Estadiamento de Neoplasias , Recidiva Local de Neoplasia/patologia , Paclitaxel/uso terapêutico , Carcinoma Epitelial do Ovário/tratamento farmacológico , Adenocarcinoma de Células Claras/cirurgia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico
2.
Taiwan J Obstet Gynecol ; 61(6): 1061-1064, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-36427975

RESUMO

OBJECTIVE: Cervical pregnancy is a rare type of ectopic pregnancy. When the pregnancy is terminated, it will sometimes lead to persistent bleeding. In some cases, hysterectomy is inevitable and the patient loses fertility. Therefore, early diagnosis and targeted management with systemic or local injection of methotrexate is the first-line treatment. Multiple interventions of cervical pregnancy were used to prevent massive hemorrhage, including dilatation and curettage, laparoscopic resection, hysteroscopic resection combined with uterine artery embolization, or uterine artery clip. CASE REPORT: We report a case of cervical pregnancy with a high beta-hCG level accompanied by a visible fetal heartbeat that was successfully treated with hysteroscopic cervical tissue resection and balloon compression combined with systemic administration of methotrexate. CONCLUSION: Efficacy and safety with preserved fertility were important issues in the management of cervical pregnancy. We provide a safe, simple and effective treatment of cervical pregnancy.


Assuntos
Abortivos não Esteroides , Oclusão com Balão , Gravidez Ectópica , Embolização da Artéria Uterina , Gravidez , Feminino , Humanos , Metotrexato/uso terapêutico , Abortivos não Esteroides/uso terapêutico , Gravidez Ectópica/tratamento farmacológico , Gravidez Ectópica/cirurgia , Hemorragia/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...